Dr. Timothy Coté and his team are dedicated to providing expert advice that enables industry leaders to successfully navigate the orphan regulatory landscape. Coté Orphan has worked with a variety organizations from biotech and large pharma to venture capital and investment firms. Learn more about how Coté Orphan can assist you.

Have a Question?

Our seasoned experts are busy at work helping our clients, but we love to answer your questions. Confused or about a drug or vaccine? We're here to clear things up.

Set Up A Time

Send us a time that's good for you and we'll set up a consultation.

Sign Up Today

Join Our Mailing list and stay up to date on news and updates on all our events, discoveries and more!

Our Upcoming Events

World Orphan Drug Congress USA

April 22-24 | Washington, DC

Read More

 New York BIO

May 4-5 | New York, NY

Read More

Recent Updates

These are the latest News & Media releases
prev next

  • Blog Post 3/27/15

    03/27/2015

    Timothy R. Coté, MD, MPH (Principal & CEO of Coté Orphan)   Pediatric Rare Disease Priority Review Voucher In recent..
    Read more

  • Read Dr. Coté’s Comments In The March Issue of Medical Marketing & Media “Rare Disease: Target Practice”

    03/27/2015

    Click here to read the article in Medical Marketing & Media. Rare Diseases Target Practice  Frank Celia, Writer An already-escalating..
    Read more

  • The Orphan Opportunity Series: Part 2 Pediatric Rare Disease Priority Review Voucher

    03/23/2015